Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2014 07/22/2014 07/23/2014 07/24/2014 07/25/2014 Date
96.31(c) 97.74(c) 98.14(c) 95.77(c) 94.96 Last
1 152 827 1 499 340 1 458 144 1 962 264 406 330 Volume
-0.92% +1.48% +0.41% -2.41% -0.85% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 543 M
EBIT 2014 -637 M
Net income 2014 -682 M
Finance 2014 431 M
Yield 2014 -
Sales 2015 1 483 M
EBIT 2015 175 M
Net income 2015 83,9 M
Finance 2015 1 266 M
Yield 2015 -
PER 2014 -
PER 2015 281,35
EV / Sales 2014 40,8x
EV / Sales 2015 14,4x
Capitalization 22 620 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
4h ago VERTEX PHARMACEUTICALS : Assigned Patent
2d ago VERTEX PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Ju..
2d ago VERTEX PHARMACEUTICALS : Patent Issued for Processes for Preparing Substituted P..
2d ago VERTEX PHARMACEUTICALS : INVESTOR ALERT: Class Action Lawsuit Against Vertex Pha..
2d ago VERTEX PHARMACEUTICALS : Peter Mueller, Ph.D to Retire from Vertex Pharmaceutica..
07/18 VERTEX PHARMACEUTICALS : Assigned Patent
07/16 VERTEX PHARMACEUTICALS : Announces Retirement of Peter Mueller, Ph.D.
07/16 VERTEX PHARMACEUTICALS : Peter Mueller, Ph.D to Retire from Vertex Pharmaceutica..
07/15 VERTEX PHARMACEUTICALS : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds In..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Ju..
07/14 NASDAQ 100 MOVERS : Vrtx, myl
07/14 VERTEX PHARMACEUTICALS : House Energy and Commerce Subcommittee on Health Hearin..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF